DJ Wallace

972 total citations
24 papers, 732 citations indexed

About

DJ Wallace is a scholar working on Rheumatology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, DJ Wallace has authored 24 papers receiving a total of 732 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Rheumatology, 11 papers in Immunology and 8 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in DJ Wallace's work include Systemic Lupus Erythematosus Research (17 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Atherosclerosis and Cardiovascular Diseases (3 papers). DJ Wallace is often cited by papers focused on Systemic Lupus Erythematosus Research (17 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Atherosclerosis and Cardiovascular Diseases (3 papers). DJ Wallace collaborates with scholars based in United States, United Kingdom and Germany. DJ Wallace's co-authors include MH Weisman, Mariko Ishimori, Dror Berel, D M Goldenberg, Meenakshi Jolly, Maura Paul‐Labrador, Nathan Fischel‐Ghodsian, John Prehn, Mariana Linker‐Israeli and Mathew Thomas and has published in prestigious journals such as Annals of the Rheumatic Diseases, Critical Care and Arthritis Research & Therapy.

In The Last Decade

DJ Wallace

24 papers receiving 712 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
DJ Wallace United States 13 555 348 136 102 62 24 732
Luís Inês Portugal 16 541 1.0× 458 1.3× 121 0.9× 98 1.0× 72 1.2× 62 837
Larissa Lisnevskaia Canada 6 505 0.9× 394 1.1× 106 0.8× 111 1.1× 47 0.8× 8 738
Laura Massaro Italy 19 768 1.4× 355 1.0× 166 1.2× 150 1.5× 125 2.0× 46 990
Viola Signorini Italy 13 487 0.9× 308 0.9× 102 0.8× 94 0.9× 47 0.8× 31 640
Henrique Ataíde Mariz Brazil 11 365 0.7× 247 0.7× 139 1.0× 147 1.4× 59 1.0× 17 695
A. Friedman United States 9 621 1.1× 337 1.0× 102 0.8× 107 1.0× 94 1.5× 25 743
Christopher Collins United States 14 523 0.9× 495 1.4× 190 1.4× 169 1.7× 50 0.8× 25 930
M. Pétri United States 17 850 1.5× 607 1.7× 210 1.5× 188 1.8× 67 1.1× 27 1.2k
E. K. Li China 18 702 1.3× 427 1.2× 87 0.6× 65 0.6× 142 2.3× 23 934
Alvaro Gómez Sweden 17 456 0.8× 288 0.8× 143 1.1× 98 1.0× 22 0.4× 43 690

Countries citing papers authored by DJ Wallace

Since Specialization
Citations

This map shows the geographic impact of DJ Wallace's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by DJ Wallace with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites DJ Wallace more than expected).

Fields of papers citing papers by DJ Wallace

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by DJ Wallace. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by DJ Wallace. The network helps show where DJ Wallace may publish in the future.

Co-authorship network of co-authors of DJ Wallace

This figure shows the co-authorship network connecting the top 25 collaborators of DJ Wallace. A scholar is included among the top collaborators of DJ Wallace based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with DJ Wallace. DJ Wallace is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dörner, Thomas, Yoshiya Tanaka, Michelle Petri, et al.. (2020). OP0045 DELINEATION OF A PROINFLAMMATORY CYTOKINE PROFILE TARGETED BY JAK1/2 INHIBITION USING BARICITINIB IN A PHASE 2 SLE TRIAL. Annals of the Rheumatic Diseases. 79. 29–30. 1 indexed citations
2.
Smith, Siobhán, et al.. (2018). TD-01 Novel IL-16/miR-125 axis controls neutrophil recruitment in pristane-induced lung inflammation. A71.2–A71. 1 indexed citations
3.
4.
Jolly, Meenakshi, S Toloza, Berna Göker, et al.. (2017). Disease-specific quality of life in patients with lupus nephritis. Lupus. 27(2). 257–264. 42 indexed citations
5.
Merrill, JT, DJ Wallace, Stephen Wax, et al.. (2017). 8 Efficacy and safety of atacicept in patients with systemic lupus erythematosus: results of a 24-week randomisedrandomized, placebo-controlled, phase iib study. INFM-OAR (INFN Catania). A4–A6. 2 indexed citations
6.
Wallace, DJ, EM Ginzler, JT Merrill, et al.. (2017). OP0232 Sustained safety and efficacy over 10 years with belimumab (BEL) plus standard systemic lupus erythematosus (SLE) therapy (SOC) in patients with SLE. Annals of the Rheumatic Diseases. 76. 150–151. 5 indexed citations
7.
Wallace, DJ, et al.. (2017). SAT0236 Safety and disease activity changes in an extension of a phase IIB study of atacicept in patients with SLE (address II). Annals of the Rheumatic Diseases. 76. 863–863. 1 indexed citations
8.
Muller, Sylviane & DJ Wallace. (2014). The importance of implementing proper selection of excipients in lupus clinical trials. Lupus. 23(7). 609–614. 13 indexed citations
9.
Wallace, DJ, Sandra Navarra, M. Pétri, et al.. (2012). Safety profile of belimumab: pooled data from placebo-controlled phase 2 and 3 studies in patients with systemic lupus erythematosus. Lupus. 22(2). 144–154. 88 indexed citations
10.
Wallace, DJ, et al.. (2012). Volume-outcome relationship in critical care: a systematic review. Critical Care. 16(S1). 1 indexed citations
11.
Rogatko, André, et al.. (2012). Prevalence of angina in patients with systemic lupus erythematosus. Arthritis Research & Therapy. 14(S3). 2 indexed citations
12.
Agarwal, Megha, et al.. (2012). Lupus cardiomyopathy: a reversible form of left ventricular dysfunction. Arthritis Research & Therapy. 14(S3). 2 indexed citations
13.
Wallace, DJ, et al.. (2011). High-sensitivity C-reactive protein and erythrocyte sedimentation rate in systemic lupus erythematosus. Lupus. 20(6). 588–597. 93 indexed citations
14.
15.
Torralba, Karina D., et al.. (2010). Depression predicts self-reported disease activity in systemic lupus erythematosus. Lupus. 20(1). 80–84. 32 indexed citations
16.
Wallace, DJ, et al.. (2009). Review: Male systemic lupus erythematosus: a review of sex disparities in this disease. Lupus. 19(2). 119–129. 133 indexed citations
17.
18.
Linker‐Israeli, Mariana, et al.. (1999). Association of IL-6 gene alleles with systemic lupus erythematosus (SLE) and with elevated IL-6 expression. Genes and Immunity. 1(1). 45–52. 81 indexed citations
19.
20.
Wallace, DJ. (1993). Systemic lupus erythematosus and the nervous system. Medical Entomology and Zoology. 370–385. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Luís Inês Breakdown of academic impact, for papers by Larissa Lisnevskaia Breakdown of academic impact, for papers by Laura Massaro Breakdown of academic impact, for papers by Viola Signorini Breakdown of academic impact, for papers by Henrique Ataíde Mariz Breakdown of academic impact, for papers by A. Friedman Breakdown of academic impact, for papers by Christopher Collins Breakdown of academic impact, for papers by M. Pétri Breakdown of academic impact, for papers by E. K. Li Breakdown of academic impact, for papers by Alvaro Gómez
Rankless by CCL
2026